“Clinical Response to Osimertinib Compared to Other Tyrosine Kinase Inhibitors and Chemotherapy in Non-Small Cell Lung Cancer”. Archives of Clinical and Medical Case Reports 4, no. 6 (November 20, 2020): 1108–1115. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22422.